Sort by
Refine Your Search
-
the National Cancer Institute (R01), foundation grants and industry partners. As a successful candidate you will: · Conduct experiments upon agreed research plan and serve on a research team involved in
-
. This project involves the development and application of interpretable machine learning methods to uncover allosteric regulation of disordered regions in the dynamics of G-protein coupled receptors to enable
-
for collecting and handling specimens; ensure proper labeling and obtain pertinent clinical and protocol information on request forms; develop and maintain knowledge of various aspects of processing specimens
-
for collecting and handling specimens; ensure proper labeling and obtain pertinent clinical and protocol information on request forms; develop and maintain knowledge of various aspects of processing specimens
-
& Therapeutics Research focuses on understanding how tumors evolve in response to treatment, using both bulk and single-cell omics approaches. We also develop AI/ML-enabled computational tools to predict
-
that is ranked top 5 in the nation for cancer care by U.S. News & World Report at its core, City of Hope’s uniquely integrated model spans cancer care, research and development, academics and training, and
-
Scientist will be responsible for the development and execution of major research projects, as well as the supervision and mentorship of junior laboratory staff. They will also be expected to collaborate with
-
tools to identify novel signaling pathways to develop new targets for drug discovery. Our research interests include: 1) Liver-gut and microbiota crosstalk as metabolic mediators in regulating both normal
-
and validate experimental plan, methods, and results for accuracy and completeness. Develop new laboratory methods and help refine existing methodologies. Your qualifications should include
-
increasingly complex research experiments to support the lab in defining the molecular mechanisms underlying normal human blood development (hematopoiesis) and leukemogenesis. This is an exciting opportunity